The Receptors That Mediate the Direct Lethality of Anthrax Toxin

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2012 Dec 29

PMID 23271637

Citations 21

Authors

Shihui Liu

Yi Zhang

Benjamin Hoover

Stephen H Leppla

Affiliations

Soon will be listed here.

Abstract

Tumor endothelium marker-8 (TEM8) and capillary morphogenesis protein-2 (CMG2) are the two well-characterized anthrax toxin receptors, each containing a von Willebrand factor A (vWA) domain responsible for anthrax protective antigen (PA) binding. Recently, a cell-based analysis was used to implicate another vWA domain-containing protein, integrin β1 as a third anthrax toxin receptor. To explore whether proteins other than TEM8 and CMG2 function as anthrax toxin receptors in vivo, we challenged mice lacking TEM8 and/or CMG2. Specifically, we used as an effector protein the fusion protein FP59, a fusion between the PA-binding domain of anthrax lethal factor (LF) and the catalytic domain of Pseudomonas aeruginosa exotoxin A. FP59 is at least 50-fold more potent than LF in the presence of PA, with 2 μg PA + 2 μg FP59 being sufficient to kill a mouse. While TEM8(-/-) and wild type control mice succumbed to a 5 μg PA + 5 μg FP59 challenge, CMG2(-/-) mice were completely resistant to this dose, confirming that CMG2 is the major anthrax toxin receptor in vivo. To detect whether any toxic effects are mediated by TEM8 or other putative receptors such as integrin β1, CMG2(-/-)/TEM8(-/-) mice were challenged with as many as five doses of 50 μg PA + 50 μg FP59. Strikingly, the CMG2(-/-)/TEM8(-/-) mice were completely resistant to the 5-dose challenge. These results strongly suggest that TEM8 is the only minor anthrax toxin receptor mediating direct lethality in vivo and that other proteins implicated as receptors do not play this role.

Citing Articles

Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?.

Tessier E, Cheutin L, Garnier A, Vigne C, Tournier J, Rougeaux C Microorganisms. 2024; 12(2).

PMID: 38399712 PMC: 10891819. DOI: 10.3390/microorganisms12020308.

Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.

Corbett V, Hallenbeck P, Rychahou P, Chauhan A Front Mol Biosci. 2022; 9:930207.

PMID: 36090051 PMC: 9458967. DOI: 10.3389/fmolb.2022.930207.

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.

Duru N, Pawar N, Martin E, Buzza M, Conway G, Lapidus R Proc Natl Acad Sci U S A. 2022; 119(28):e2201423119.

PMID: 35867758 PMC: 9282395. DOI: 10.1073/pnas.2201423119.

Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.

Cryan L, Tsang T, Stiles J, Bazinet L, Lee S, Garrard S Angiogenesis. 2022; 25(3):397-410.

PMID: 35212873 PMC: 9250616. DOI: 10.1007/s10456-022-09833-w.

Enhanced Collagen Deposition in the Duodenum of Patients with Hyaline Fibromatosis Syndrome and Protein Losing Enteropathy.

van Rijn J, Werner L, Aydemir Y, Spronck J, Pode-Shakked B, van Hoesel M Int J Mol Sci. 2020; 21(21).

PMID: 33147779 PMC: 7662532. DOI: 10.3390/ijms21218200.

References

Duesbery N, Webb C, Leppla S, Gordon V, Klimpel K, Copeland T . Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998; 280(5364):734-7. DOI: 10.1126/science.280.5364.734. View

Martchenko M, Jeong S, Cohen S . Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci U S A. 2010; 107(35):15583-8. PMC: 2932583. DOI: 10.1073/pnas.1010145107. View

Gupta P, Moayeri M, Crown D, Fattah R, Leppla S . Role of N-terminal amino acids in the potency of anthrax lethal factor. PLoS One. 2008; 3(9):e3130. PMC: 2518864. DOI: 10.1371/journal.pone.0003130. View

Arora N, Klimpel K, Singh Y, Leppla S . Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J Biol Chem. 1992; 267(22):15542-8. View

Liu S, Leppla S . Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J Biol Chem. 2002; 278(7):5227-34. DOI: 10.1074/jbc.M210321200. View

Liu S, Bachran C, Gupta P, Miller-Randolph S, Wang H, Crown D . Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development. Proc Natl Acad Sci U S A. 2012; 109(34):13817-22. PMC: 3427129. DOI: 10.1073/pnas.1206933109. View

Liu S, Leppla S . Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylating toxins. Mol Cell. 2003; 12(3):603-13. DOI: 10.1016/j.molcel.2003.08.003. View

Liu S, Leung H, Leppla S . Characterization of the interaction between anthrax toxin and its cellular receptors. Cell Microbiol. 2007; 9(4):977-87. PMC: 2459336. DOI: 10.1111/j.1462-5822.2006.00845.x. View

Liu S, Wang H, Currie B, Molinolo A, Leung H, Moayeri M . Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem. 2007; 283(1):529-540. PMC: 2394502. DOI: 10.1074/jbc.M707419200. View

10.

Newman Z, Printz M, Liu S, Crown D, Breen L, Miller-Randolph S . Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS Pathog. 2010; 6(5):e1000906. PMC: 2873920. DOI: 10.1371/journal.ppat.1000906. View

11.

Abrami L, Leppla S, van der Goot F . Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol. 2006; 172(2):309-20. PMC: 2063559. DOI: 10.1083/jcb.200507067. View

12.

Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C . Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J. 2000; 352 Pt 3:739-45. PMC: 1221512. View

13.

Scobie H, Rainey G, Bradley K, Young J . Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A. 2003; 100(9):5170-4. PMC: 154317. DOI: 10.1073/pnas.0431098100. View

14.

Levinsohn J, Newman Z, Hellmich K, Fattah R, Getz M, Liu S . Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog. 2012; 8(3):e1002638. PMC: 3315489. DOI: 10.1371/journal.ppat.1002638. View

15.

Leppla S . Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A. 1982; 79(10):3162-6. PMC: 346374. DOI: 10.1073/pnas.79.10.3162. View

16.

Abi-Habib R, Singh R, Leppla S, Greene J, Ding Y, Berghuis B . Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice. Clin Cancer Res. 2006; 12(24):7437-43. DOI: 10.1158/1078-0432.CCR-06-2019. View

17.

Liu S, Miller-Randolph S, Crown D, Moayeri M, Sastalla I, Okugawa S . Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe. 2010; 8(5):455-62. PMC: 3032408. DOI: 10.1016/j.chom.2010.10.004. View

18.

Pomerantsev A, Pomerantseva O, Moayeri M, Fattah R, Tallant C, Leppla S . A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins. Protein Expr Purif. 2011; 80(1):80-90. PMC: 3183367. DOI: 10.1016/j.pep.2011.05.016. View

19.

Moayeri M, Leppla S . Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med. 2009; 30(6):439-55. PMC: 2784088. DOI: 10.1016/j.mam.2009.07.003. View

20.

Abrami L, Liu S, Cosson P, Leppla S, van der Goot F . Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol. 2003; 160(3):321-8. PMC: 2172673. DOI: 10.1083/jcb.200211018. View